Search Tag: antibodies
2023 19 Sep
Xencor, Inc., a clinical-stage biopharmaceutical company developing engineered antibodies and cytokines for the treatment of cancer and autoimmune diseases announced the appointment of Barbara J. Klencke, M.D., to its board of directors. Dr. Klencke has more than 20 years of biopharmaceutical product development experience, and she most recently served...Read more
2015 03 Jul
As the South Korean epidemic of Middle East Respiratory Syndrome (MERS) continues unabated, University of Maryland School of Medicine scientists have announced the discovery of two therapeutics that show potential in preventing and treating the disease. The treatments are the first to succeed in protecting and treating animal models of the MERS virus;...Read more
2015 22 Apr
A new technique that allows real-time, noninvasive imaging of the immune system’s response to the presence of tumours offers a potential breakthrough both in diagnostics and in monitoring efficacy of cancer therapies. Developed in the lab of Whitehead Institute Member Hidde Ploegh, the method utilises the imaging power of positron emission tomography...Read more